Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: a randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes (Q46649728)
Jump to navigation
Jump to search
scientific article published in March 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: a randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes |
scientific article published in March 2008 |
Statements
1 reference
Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: a randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes (English)
1 reference
Paul Covington
1 reference
Ronald Christopher
1 reference
Michael Davenport
1 reference
Penny Fleck
1 reference
Qais A Mekki
1 reference
Elisabeth R Wann
1 reference
Aziz Karim
1 reference
1 March 2008
1 reference
1 reference
30
1 reference
3
1 reference
499-512
1 reference